Company: JUNS
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001493152-25-023603
Chunk: 121

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-11-14
Form: 10-Q
Item: Item 1
Chunk 121
---
 income (loss) 
     -  
     -  
     -  
     -  
     (911,998) 
     (911,998)

    September
    30, 2024 
     30,126,413  
    $3,012  
    $18,815,494  
    $(75,000) 
    $(24,494,502) 
    $(5,750,996)
  
    Balance 
     30,126,413  
    $3,012  
    $18,815,494  
    $(75,000) 
    $(24,494,502) 
    $(5,750,996)

The
accompanying notes are an integral part of these condensed consolidated financial statements

6

JUPITER
NEUROSCIENCES, INC.

CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

    September
    30,  2025  
    September
    30,  2024 
  
    Cash
    Flows from Operating Activities: 

    Net
    Loss 
    $(6,069,866) 
    $(911,998)
  
    Adjustments
    to reconcile net loss to net cash used in operating activities: 

    Loss
    on change in fair value of derivative liability 
     -  
     53,257 
  
    Amortization
    of debt discounts 
     -  
     15,013 
  
    Gain
    on extinguishment of debt 
     -  
     (951,868)
  
    Gain
    on forgiveness of accrued compensation 
     -  
     (40,000)
  
    Non-
    cash amortization of prepaid contracts 
     573,424  
     - 
  
    Stock-based
    compensation 
     1,955,275  
     827,357 
  
    Changes
    in operating assets and liabilities: 

    Prepaid
    and other current assets 
     (27,808) 
     25,000 
  
    Operating
    lease right of use asset 
     (2,547) 
     (1,151)
  
    Increase in other liabilities 
     6,695  
     - 
  
    Accounts
    payable and accrued expenses